Resources
-
Posted: March 01, 2024Categories: ichorbio Citations
Intratumoral Delivery of Interleukin 9 via Oncolytic Vaccinia Virus Elicits Potent Antitumor Effects in Tumor Models
by Junjie Ye, Lingjuan Chen, Julia Waltermire, Jinshun Zhao, Jinghua Ren, Zongsheng Guo, David L. Bartlett, and Zuqiang Liu
Cancers 2024, 16(5), 1021
https://doi.org/10.3390/cancers16051021
Researchers from Allegheny...
-
Posted: February 28, 2024Categories: ichorbio Citations
Benguigui et al., 2024, Cancer Cell 42, 253–265
https://doi.org/10.1016/j.ccell.2023.12.005Researchers from the Technion - Israel Institute of Technology and their collaborators have discovered a promising new biomarker for predicting patient response to cancer immunotherapy: interferon-stimulated neutrophils expressing high levels of the Ly6E protein (Ly6E(hi)...
-
-
Posted: February 14, 2024Categories: ichorbio Citations
This article is based on research found in the following publication:
Mine, K., Nagafuchi, S., Akazawa, S. et al. TYK2 signaling promotes the development of autoreactive CD8+ cytotoxic T lymphocytes and type 1 diabetes. Nat Commun15, 1337 (2024). https://doi.org/10.1038/s41467-024-45573-9
Type 1 diabetes (T1D) is an autoimmune disease where the body's...
-
Posted: February 01, 2024Categories: Antibodies in Clinic / Clinical Trials
Antibody therapeutics have made significant strides in recent years, with several successful treatments already in the market. However, the future of this field lies in the promising candidates currently in Phase I-II clinical trials. These antibodies, targeting a wide range of diseases, have the potential to become important treatments in the coming years.
One such antibody is DSP-0038, a humanized monoclonal antibody targeting the TROP2... -
Posted: January 26, 2024Categories: Antibodies in Clinic / Clinical Trials
1. Target and Function
Belimumab is a human monoclonal antibody that targets and inhibits the biological activity of B-cell activating factor (BAFF), also known as B-lymphocyte stimulator (BLyS) [1]. BAFF is a crucial survival factor for B cells and plays a significant role in the pathogenesis of systemic lupus erythematosus (SLE) [2].
2. Medical Uses
Belimumab is approved for the treatment of active, autoantibody-positive... -
Posted: January 08, 2024Categories: Antibodies in Clinic / Clinical Trials
1. Target and Function
Tabalumab is a human monoclonal antibody that neutralizes both soluble and membrane-bound forms of B-cell activating factor (BAFF), a cytokine that promotes B-cell survival and differentiation [1]. By blocking BAFF, Tabalumab reduces B-cell numbers and activity, which may be beneficial in autoimmune diseases [2].
2. Medical Uses
Tabalumab has been investigated for the treatment of systemic... -
Posted: January 05, 2024Categories: Antibodies in Clinic / Clinical Trials
1. Target and Function
Belantamab mafodotin is an antibody-drug conjugate (ADC) that targets B-cell maturation antigen (BCMA), a protein expressed on the surface of multiple myeloma cells [1]. The antibody is conjugated to monomethyl auristatin F (MMAF), a potent microtubule-disrupting agent, which induces cell death upon internalization [2].
2. Medical Uses
Belantamab is approved for the treatment of adult patients... -
Posted: January 01, 2024Categories: Antibodies in Clinic / Clinical Trials
1. Target and Function
Aducanumab is a human monoclonal antibody that selectively targets amyloid-beta (Aβ) aggregates, a pathological hallmark of Alzheimer's disease (AD) [1]. By binding to Aβ, aducanumab promotes its clearance and reduces the formation of amyloid plaques in the brain [2].
2. Medical UsesAducanumab is approved by the U.S. Food and Drug Administration (FDA) for the treatment of AD, specifically for patients w...
-
Posted: December 24, 2023Categories: PhD Guides
Pursuing a PhD is a challenging and rewarding journey that requires dedication, perseverance, and strategic planning. While the path to a successful PhD is unique for each individual, there are several key principles that can help doctoral candidates navigate the process and achieve their goals. From developing a strong research plan to cultivating professional relationships, this guide offers insights into making your PhD a success.
One...